
Mark W Russell MD
Associate Professor, Pediatrics & Communicable Diseases, University of Michigan Medical School
Request Appointment
1500 E Medical Center Dr1st Floor Mott Hospital Recp FAnn Arbor, MI 48109
Overview of Dr. Russell
Dr. Mark Russell is a pediatric cardiologist in Ann Arbor, MI and is affiliated with University of Michigan Medical Center. He received his medical degree from Duke University School of Medicine and has been in practice 28 years. Dr. Russell accepts several types of health insurance, listed below. He is one of 84 doctors at University of Michigan Medical Center who specialize in Pediatric Cardiology. He has more than 100 publications and over 500 citings.
Education & Training
- University of MichiganFellowship, Pediatric Cardiology, 1992 - 1996
- Johns Hopkins UniversityResidency, Pediatrics, 1989 - 1992
- Duke University School of MedicineClass of 1989
Certifications & Licensure
- MI State Medical License 1993 - 2025
- VA State Medical License 2000 - 2018
- MD State Medical License 1991 - 1995
- American Board of Pediatrics Pediatric Cardiology
Clinical Trials
- Pilot/Ph I Safety and Efficacy of ODSH in Protein Losing Enteropathy Secondary to Single Ventricle Palliative Surgery Start of enrollment: 2010 Jul 01
- Genetic Determinants of Congenital Heart Disease Outcomes Start of enrollment: 2011 Mar 01
- Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM Start of enrollment: 2014 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- Methylated Arginine Metabolites as Biomarkers for Clinical Status and Response to Type 5 Phosphodiesterase Inhibition in Patients With Fontan Circulation.Ari Cedars, Cedric Manlhiot, Bhargava Kumar Chinni, Alexander R Opotowsky, Kristian Becker
Journal of the American Heart Association. 2025-04-01 - Low Penetrance Sarcomere Variants Contribute to Additive Risk in Hypertrophic Cardiomyopathy.Joshua K Meisner, Aaron Renberg, Eric D Smith, Yao-Chang Tsan, Brynn Elder
Circulation. 2025-03-18 - Valsartan and Cardiac Remodeling in Early-Stage Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical Trial Cardiac Magnetic Resonance Substudy.John W Ostrominski, Brian L Claggett, Michael Jerosch-Herold, Anna Axelsson Raja, Sharlene M Day
JAMA Cardiology. 2025-03-05
Grant Support
- Role Of Obscurin And Obscurin-Mlck In MyofibrillogenesisNational Heart, Lung, And Blood Institute2005–2008
- Cloning Of A Potential Regulator Of The Dhand FactorEunice Kennedy Shriver National Institute Of Child Health &Human Development2001–2002
- Gene Targets Of The Cardiac Specific Homeobox (CSX) GeneNational Heart, Lung, And Blood Institute1997–2001
- Linkage Analysis Of The Long QT SyndromeNational Center For Research Resources1996–2000
- Positional Cloning Of The Gene For The Long OT SyndromeNational Heart, Lung, And Blood Institute1993
Insurance Accepted
- Aetna Choice POS II
BCBS Blue Card PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Cofinity PPOFirst Health PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
PriorityHealth HMO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: